What is it about?
A randomized trial presented at ESTRO 2019 shows that radiotherapy performed with high doses increases survival in MPM patients vs palliative treatments. A retrospective study of patients treated with high dose radiotherapy when in progressive disease after surgery/chemiotherapy gives some indications on patients selection based on gross tumor volume at PET/CT.
Featured Image
Why is it important?
Integrated treatments can increase survival in MPM.
Perspectives
Randomized trials with a better integration of treatments.
Dr. Andrei Fodor
San Raffaele Scientific Institute, Milan, Italy
Read the Original
This page is a summary of: The “Radical” Palliation That Increases Survival in Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, December 2019, Elsevier,
DOI: 10.1016/j.jtho.2019.07.030.
You can read the full text:
Contributors
The following have contributed to this page
